Starpharma Holdings Limited (SPHRF) Stock Statistics & Valuation Metrics

Starpharma Holdings Limited has a market cap or net worth of $282.71M. The enterprise value is $284.34.

Starpharma Holdings Limited has 477,054,960 shares outstanding. The number of shares has decreased by -2.65% in one year.

Starpharma Holdings Limited’s return on equity (ROE) is -0.54 and return on invested capital (ROIC) is -52.98%.

The current PE Ratio of Starpharma Holdings Limited is ―. Starpharma Holdings Limited’s PEG ratio is 1.43.

In the last 12 months, Starpharma Holdings Limited had revenue of 12.05M and earned -7.46M in profits. Earnings per share was -0.02.

In the last 12 months, operating cash flow was -3.21M and capital expenditures -287.00K, giving a free cash flow of -3.50M billion.

Starpharma Holdings Limited pays an annual dividend of ―, resulting in a dividend yield of ―

Starpharma Holdings Limited upcoming earnings date is Mar 2, 2027, TBA (Confirmed).

Starpharma Holdings Limited as a current ratio of 3.40, with Debt / Equity ratio of 5.13%

In the past 12 months, Starpharma Holdings Limited has paid -11.15M in taxes.

Starpharma Holdings Limited EV to EBITDA ratio is -15.47, with an EV/FCF ratio of -81.07.

Starpharma Holdings Limited has $11.02M in cash and marketable securities with $707.00K in debt, giving a net cash position of $10.31M billion.

Gross margin is 86.26%, with operating margin of -159.60%, and net profit margin of -61.95%.

The average price target for Starpharma Holdings Limited is ―, which is 11.43% higher than the current price. The consensus rating is ―